We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,014 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 356 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more funds holding in top 10

Funds holding in top 10: 23 → 38 (+15)

46% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 68

16% more capital invested

Capital invested by funds: $50.9B → $59B (+$8.14B)

2% more funds holding

Funds holding: 992 → 1,014 (+22)

1.38% more ownership

Funds ownership: 87.77% → 89.15% (+1.4%)

7% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 356

22% less call options, than puts

Call options by funds: $974M | Put options by funds: $1.24B

Holders
1,014
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.28%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
356
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$513M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$310M
3
Ameriprise
Ameriprise
Minnesota
+$178M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$167M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$133M

Top Sellers

1
BlackRock
BlackRock
New York
-$344M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$206M
3
Renaissance Technologies
Renaissance Technologies
New York
-$190M
4
SIG
Senator Investment Group
New York
-$136M
5
Citadel Advisors
Citadel Advisors
Florida
-$119M
Name Holding Trade Value Shares
Change 		Change in
Stake
LMGAM
451
Liberty Mutual Group Asset Management
Massachusetts
$2.77M -$4.96M -16,761 -65%
FDCDDQ
452
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2.73M -$136K -458 -5%
TMAM
453
Tokio Marine Asset Management
Japan
$2.71M -$209K -706 -8%
AIIMS
454
Analyst IMS Investment Management Services
Israel
$2.69M -$8.88K -30 -0.3%
LWCFA
455
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$2.67M +$3.26K +11 +0.1%
Victory Capital Management
456
Victory Capital Management
Texas
$2.64M +$169K +570 +7%
Marshall Wace
457
Marshall Wace
United Kingdom
$2.63M +$1.08M +3,632 +76%
APFBOT
458
Amica Pension Fund Board of Trustees
Rhode Island
$2.59M – – –
ECM
459
ETrade Capital Management
Virginia
$2.51M +$162K +546 +7%
Squarepoint
460
Squarepoint
New York
$2.5M +$2.37M +8,001 New
LNB
461
Ledyard National Bank
$2.5M +$38.2K +129 +2%
Pacer Advisors
462
Pacer Advisors
Pennsylvania
$2.5M +$283K +957 +14%
QI
463
Quotient Investors
New York
$2.49M +$13.6K +46 +0.6%
Simplex Trading
464
Simplex Trading
Illinois
$2.47M +$2.33M +7,879 New
Daiwa Securities Group
465
Daiwa Securities Group
Japan
$2.44M +$467K +1,576 +25%
Brown Advisory
466
Brown Advisory
Maryland
$2.44M -$1.46M -4,942 -39%
OMCS
467
Old Mutual Customised Solutions
South Africa
$2.44M +$118K +400 +5%
OSNBOA
468
Old Second National Bank of Aurora
Illinois
$2.44M +$7.7K +26 +0.3%
FAM
469
Fred Alger Management
New York
$2.44M +$370K +1,250 +19%
PS
470
Pensionfund Sabic
Netherlands
$2.41M – – –
AW
471
ACG Wealth
Georgia
$2.4M +$19.2K +65 +0.9%
WF
472
Welch & Forbes
Massachusetts
$2.4M -$69K -233 -3%
NLI
473
Nippon Life Insurance
Japan
$2.39M +$56.3K +190 +3%
MWAC
474
Mariner Wealth Advisors (Cincinnati)
Ohio
$2.37M +$58.9K +199 +3%
PCM
475
Prelude Capital Management
New York
$2.37M +$1.48M +4,993 +194%
17 18
19
20 21

BIIB Hedge Fund Activity: Q3 2017 in Review

1,014 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2017, worth a combined $59B — up 16% from $50.9B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new BIIB positions and 68 closed out — a net gain of 31 holders — while 380 added to existing stakes and 356 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $513M. The largest seller was BlackRock, cutting an estimated $344M.

  • 1,014 institutional investors held Biogen (BIIB) as of Q3 2017, up from 992 in Q2 2017.
  • Funds reported $59B of Biogen stock for Q3 2017, up 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2017 and 68 closed out, a net change of +31 holders.
  • The largest Biogen buyer in Q3 2017 was T. Rowe Price Associates, an estimated $513M added.
  • The largest Biogen seller in Q3 2017 was BlackRock, an estimated $344M sold.

Based on aggregated 13F filings for Q3 2017.